BWM
CVS icon

BerganKDV Wealth Management’s CVS Health CVS Stock Holding History

BerganKDV Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.93M Buy
27,926
+76
+0.3% +$5.41K 0.19% 91
2023
Q1 		$2.07M Buy
27,850
+105
+0.4% +$8.8K 0.21% 83
2022
Q4 		$2.59M Buy
27,745
+361
+1% +$34.8K 0.28% 73
2022
Q3 		$2.61M Buy
27,384
+210
+0.8% +$20.8K 0.31% 68
2022
Q2 		$2.52M Buy
27,174
+287
+1% +$28K 0.29% 78
2022
Q1 		$2.72M Buy
26,887
+1,577
+6% +$166K 0.29% 73
2021
Q4 		$2.61M Sell
25,310
-281
-1% -$26K 0.27% 79
2021
Q3 		$2.17M Buy
25,591
+1,013
+4% +$84.9K 0.25% 82
2021
Q2 		$2.05M Buy
24,578
+148
+0.6% +$12.1K 0.24% 83
2021
Q1 		$1.84M Sell
24,430
-2,142
-8% -$156K 0.24% 83
2020
Q4 		$1.81M Sell
26,572
-1,065
-4% -$69.3K 0.26% 80
2020
Q3 		$1.61M Sell
27,637
-2,089
-7% -$130K 0.26% 83
2020
Q2 		$1.93M Sell
29,726
-27,197
-48% -$1.71M 0.33% 69
2020
Q1 		$3.38M Buy
56,923
+9,883
+21% +$660K 0.69% 30
2019
Q4 		$3.5M Sell
47,040
-112
-0.2% -$7.86K 0.62% 34
2019
Q3 		$2.97M Buy
47,152
+196
+0.4% +$11.6K 0.59% 33
2019
Q2 		$2.56M Buy
46,956
+29,168
+164% +$1.57M 0.51% 41
2019
Q1 		$959K Buy
17,788
+3,299
+23% +$204K 0.2% 92
2018
Q4 		$949K Buy
14,489
+2,435
+20% +$182K 0.22% 83
2018
Q3 		$949K Sell
12,054
-1,400
-10% -$100K 0.2% 86
2018
Q2 		$866K Buy
13,454
+1,268
+10% +$83.6K 0.19% 99
2018
Q1 		$758K Buy
12,186
+2,914
+31% +$209K 0.21% 102
2017
Q4 		$672K Sell
9,272
-547
-6% -$39.8K 0.16% 112
2017
Q3 		$799K Buy
9,819
+118
+1% +$9.33K 0.2% 98
2017
Q2 		$781K Buy
9,701
+1,357
+16% +$107K 0.22% 89
2017
Q1 		$655K Buy
8,344
+1,235
+17% +$98.6K 0.19% 105
2016
Q4 		$561K Buy
7,109
+864
+14% +$69.9K 0.19% 109
2016
Q3 		$556K Buy
+6,245
New +$589K 0.19% 107

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BerganKDV Wealth Management's CVS Position: Q2 2023 in Review

BerganKDV Wealth Management increased its CVS Health (CVS) stake by 0.27% in Q2 2023, buying an estimated $5.41K and bringing the position to 27,926 shares worth $1.93M. The position accounts for 0.19% of the portfolio, ranked #91.

BerganKDV Wealth Management first reported a position in CVS in Q3 2016 and has held it in 28 quarters since. The position peaked at $3.5M in Q4 2019. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • BerganKDV Wealth Management held 27,926 shares of CVS Health worth $1.93M as of Q2 2023.
  • BerganKDV Wealth Management bought 76 CVS Health shares in Q2 2023, an estimated $5.41K.
  • CVS Health made up 0.19% of BerganKDV Wealth Management's portfolio in Q2 2023, its #91 holding.
  • BerganKDV Wealth Management first reported a position in CVS Health in Q3 2016 and has held it in 28 quarters since.
  • BerganKDV Wealth Management's CVS Health position peaked at $3.5M in Q4 2019.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.